Hims & Hers Health ( HIMS -7.38%) stock slid 7.4% through 11:10 a.m. ET Tuesday after Bank of America raised its price target ...

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 8% in the afternoon session after the U.S. Food and Drug ...

We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where Hims & ...

Palantir has been one of the most successful and beloved investments for many growth investors over the last few years. Read ...

When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...

My current strategy combines dividend growth investing with Big Picture research. Check out my take on the 10 Rules of ...

BofA raised the firm’s price target on Hims & Hers to $22 from $21 and keeps an Underperform rating on the shares. February observed sales ...

As the U.S. equities market rebounds from a recent slump, investors are closely watching for opportunities amid ongoing economic uncertainties and policy shifts. In such a landscape, companies with ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Here is how the Barron’s Roundtable members’ picks performed. Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the ...